Holen Sie sich die Stockscreener-App
76.40
0.24%
-0.18
Handel nachbörslich:
76.40
Schlusskurs vom Vortag:
$76.58
Offen:
$76.04
24-Stunden-Volumen:
1.30M
Relative Volume:
0.94
Marktkapitalisierung:
$8.70B
Einnahmen:
$13.18B
Nettoeinkommen (Verlust:
$419.00M
KGV:
23.36
EPS:
3.2704
Netto-Cashflow:
$521.00M
1W Leistung:
+2.95%
1M Leistung:
+3.34%
6M Leistung:
+4.50%
1J Leistung:
+9.16%
1-Tages-Spanne:
$75.74
$77.04
1-Wochen-Bereich:
$73.60
$78.04
52-Wochen-Spanne:
$61.95
$89.29
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
76.40 | 8.72B | 13.18B | 419.00M | 521.00M | 3.2704 |
MCK
Mckesson Corp
|
734.82 | 89.24B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
264.69 | 52.41B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
195.15 | 46.09B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
1.49 | 1.30B | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-16 | Eingeleitet | BTIG Research | Neutral |
| 2026-04-15 | Eingeleitet | Citigroup | Buy |
| 2026-02-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-08-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2025-07-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring A 13.89% Potential Upside - DirectorsTalk Interviews
How Henry Schein’s New Chairman and Governance Shift At Henry Schein (HSIC) Has Changed Its Investment Story - simplywall.st
Henry Schein stock: Is Wall Street bullish or bearish? - MSN
Henry Schein Sees Steady Dental Demand, $125M Profit Lift by 2026 - Yahoo Finance
Here's why Henry Schein (HSIC) is a strong momentum stock - MSN
Henry Schein (NASDAQ: HSIC) SVP files Form 3 on share and option holdings - Stock Titan
Here's Why Henry Schein (HSIC) is a Strong Momentum Stock - Yahoo Finance
Is This the Right Time to Keep HSIC Stock in Your Portfolio? - TradingView
Dental giant Henry Schein announces new independent chairman of the board - Dental Tribune US
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein (HSIC) ex-director corrects date on 50-share stock gift - Stock Titan
Henry Schein stock (US42548G1040): Dental and medical distributor navigates shifting US healthcare d - AD HOC NEWS
Henry Schein, Inc. (HSIC) Stock Analysis: Healthcare Distributor with 17.52% Potential Upside - DirectorsTalk Interviews
Henry Schein highlights dental momentum, $125M savings goal despite medical softness - MSN
Henry Schein appoints William Daniel as independent chairman - Investing.com UK
Henry Schein (HSIC) director reports bona fide 50-share stock gift - Stock Titan
Henry Schein Elects William K. “Dan” Daniel as Independent Chairman of the Board, Succeeding Stan Bergman After 44 Years - Minichart
Henry Schein appoints William Daniel as independent chairman By Investing.com - Investing.com South Africa
Henry Schein, Inc. (HSIC) Announces Key Decisions from 2026 Annu - GuruFocus
Here's Why Henry Schein (HSIC) is a Strong Value Stock - Yahoo Finance
Henry Schein Names William K. Daniel as Independent Chairman - Moomoo
Henry Schein Names New Board Chairman - Dentistry Today
Henry Schein announces the election of William K. "Dan" Daniel as independent chairman of the board - marketscreener.com
Dan Daniel becomes Henry Schein (HSIC) independent chair as Bergman retires - Stock Titan
Henry Schein Announces the Election of William K. “Dan” Daniel as Independent Chairman of the Board - Business Wire
Henry Schein Governance Push Meets Discounted Valuation And Mixed Share Performance - Sahm
Henry Schein (HSIC) director Stanley Bergman gifts 1,040 shares - Stock Titan
Henry Schein stock (US42548G1040): Q1 2026 results and outlook update put margins in the spotlight - AD HOC NEWS
Assessing Henry Schein (HSIC) Valuation After Recent Uneven Share Price Performance - Yahoo Finance
Henry Schein Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Henry Schein stock (US42548G1040): Q1 results and outlook update draw investor focus - AD HOC NEWS
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 19.93% Potential Upside in Medical Distribution - DirectorsTalk Interviews
Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness - MarketBeat
A Look At Henry Schein (HSIC) Valuation After Solid Q1 Update And Reaffirmed Guidance - Sahm
Why Henry Schein (HSIC) is a top value stock for the long term - MSN
Citigroup initiates coverage of Henry Schein (HSIC) with buy recommendation - MSN
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Insulet (PODD) and Gilead Sciences (GILD) - The Globe and Mail
LONE PEAK VALUE FUND's Henry Schein Inc(HSIC) Holding History - GuruFocus
An Insider Of Henry Schein Picks Up 100% More Stock - simplywall.st
5 Must-Read Analyst Questions From Henry Schein’s Q1 Earnings Call - Yahoo Finance
Henry Schein Inc (HSIC) Stock Up 4.5% and Still Undervalued -- G - GuruFocus
Henry Schein One Releases 2026 Catalyst Index - Dentistry Today
Henry Schein One Releases 2026 Catalyst Index, Revealing Clinical Performance as the Primary Driver of Growth - 01net
Henry Schein Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Henry Schein (HSIC) director boosts stake with 10,000-share open-market buy via trust - Stock Titan
Henry Schein beats Q1 earnings with $1.32 EPS, 6.3% revenue growth - eciks.org
Henry Schein : 2026 Proxy Supplement May 12, 2026 of 2025 - marketscreener.com
Right to Read, but Wrong to Write - Health API Guy
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein, Inc. $HSIC Holdings Increased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.97%
3.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):